Comparison of Splanchnic Nerve Block with Ropivacaine/ Depo Medrol and Ropivacaine/Depo Medrol/Fentanyl in Patients Suffering from Abdominal Pain Due to Pancreatic Cancer
,
Abstract
Background: This double-blind clinical trial aimed to investigate the effectiveness of splanchnic nerve blocks using different medication combinations on pain severity and duration of pain relief in patients with pancreatic cancer-related abdominal pain.
Methods: Thirty eligible patients were randomly assigned to either a control group receiving splanchnic blocks with Ropivacaine/Depo Medrol/Saline or an intervention group receiving splanchnic blocks with Ropivacaine/Depo Medrol/Fentanyl. Pain severity was assessed using the Numeric Rating Scale (NRS) at 2, 6, and 24 hours and one week post-intervention. Statistical analysis included independent t-tests, Friedman tests, and False Discovery Rate (FDR) correction.
Results: Prior to intervention, no significant difference in NRS scores was observed between groups (p = 0.0642). However, at the 6-hour and one-week intervals, the case group exhibited significantly lower NRS scores than the control group, indicating the efficacy of the intervention in reducing pain levels. The case group showed a substantial decrease in NRS scores from a pre-intervention mean of 7.8 to 0.5 at 2 hours, while the control group experienced a reduction from 9.083 to 2.583. The mean duration of pain relief was longer in the case group (5.429 days) compared to the control group (3.25 days). Friedman tests revealed significant differences in pain scores across time intervals within both groups (p < 0.001).
Conclusion: Splanchnic nerve blocks using Ropivacaine/Depo Medrol/Fentanyl combination demonstrated significant pain reduction effects, particularly at 6 hours and one-week post-intervention, compared to the control group. These findings showed that the addition of fentanyl in pharmaceutical combination as a opioid to the splanchnic block has reduced the pain score and increase the duration of pain relief in patients being involved in pancreatic cancer with abdominal pain.
[2] Lilly AC, Astsaturov I, Golemis EA. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol Life Sci. 2023; 80(8):206.
[3] Kandikattu HK, Venkateshaiah SU, Mishra A. Chronic Pancreatitis and the Development of Pancreatic Cancer. Endocr Metab Immune Disord Drug Targets. 2020; 20(8):1182-1210.
[4] Scott E, Jewell A. Supportive care needs of people with pancreatic cancer: a literature review. Cancer Nursing Practice. 2023 Jul 3;22(4).
[5] Pezzilli R, Caccialanza R, Capurso G, Brunetti O, Milella M, Falconi M. Pancreatic enzyme replacement therapy in pancreatic cancer. Cancers. 2020; 12(2):275.
[6] Bozkirli B, Piyade B, Sisman G, Ceyhan G. Pain in Pancreatic Cancer: Mechanisms and Management. Textbook of Pancreatic Cancer: Principles and Practice of Surgical Oncology. 2021:1203-13.
[7] Häuser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, et al. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: Role of opioids in the management of chronic noncancer pain. Eur J Pain. 2021; 25(5):949-968.
[8] Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019; 12(2):113-122.
[9] Tuan J, Wang EH, De Leon JR, Mendoza MJ, Varrassi G, De Leon JR. Management of Acute Cancer Pain in Asia: An Expert Opinion on the Role of Tramadol/Dexketoprofen Fixed-Dose Combination. Cureus. 2023; 15(3).
[10] Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Dico SL, et al. Neuropathic pain: clinical classification and assessment in patients with pain due to cancer. Pain. 2021; 162(3):866.
[11] Ho JF, Yaakup H, Low GS, Wong SL, Tho LM, Tan SB. Morphine use for cancer pain: A strong analgesic used only at the end of life? A qualitative study on attitudes and perceptions of morphine in patients with advanced cancer and their caregivers. Palliative medicine. 2020; 34(5):619-29.
[12] Coveler AL, Mizrahi J, Eastman B, Apisarnthanarax SJ, Dalal S, McNearney T, et al. Pancreas cancer-associated pain management. The oncologist. 2021; 26(6):e971-82.
[13] Cai W, Liu F, Wen Y, Han C, Prasad M, Xia Q, et al. Pain management in acute pancreatitis: a systematic review and meta-analysis of randomised controlled trials. Front Med. 2021; 8:782151.
[14] Lima E, Lima M, Romão C. Pain Management in PCI: Analgesia and Anesthesia. Percutaneous Collagen Induction with Microneedling: A Step-by-Step Clinical Guide. 2021:27-47.
[15] Edinoff AN, Kaplan LA, Khan S, Petersen M, Sauce E, Causey CD, et al. Full opioid agonists and tramadol: pharmacological and clinical considerations. Anesth Pain Med. 2021; 11(4).
[16] Akhondzadeh R, Olapour A, Javaherforooshzadeh F, Rashidi M, Bakhtiari N, Hosseininejad F. Dexmedetomidine or Fentanyl, Which One is Better as an Adjunct Drug in Epidural Anesthesia and Causes More Postoperative Pain Reduction? A Comparative Study, a Randomized Clinical Trial. Anesth Pain Med. 2023; 13(1).
[17] Paul A, Borkar A. Fluoroscopy-Guided Splanchnic Nerve Block for Cancer-Associated Pain. Cureus. 2022; 14(10).
[18] Urits I, Jones MR, Orhurhu V, Peck J, Corrigan D, Hubble A, et al. A comprehensive review of the celiac plexus block for the management of chronic abdominal pain. Current Pain and Headache Reports. 2020; 24.
[19] Comlek S. Pain control with splanchnic neurolysis in pancreatic cancer patients unresponsive to celiac plexus neurolysis. J Pain Res. 2020; 2023-31.
[20] Liu SS, Moore JM, Luo AM, Trautman WJ, Carpenter RL. Comparison of three solutions of ropivacaine/fentanyl for postoperative patient-controlled epidural analgesia. Anesthesiology. 1999; 90(3):727-33.
[21] Kang HY, Lee CH, Choi SS, Lee MK, Lee YJ, Park JS. Comparison of the Analgesic Effect of Ropivacaine with Fentanyl and Ropivacaine Alone in Continuous Epidural Infusion for Acute Herpes Zoster Management: A Retrospective Study. Medicina (Kaunas). 2020; 56(1):22.
[22] Chaudhary A, Bogra J, Singh PK, Saxena S, Chandra G, Verma R. Efficacy of spinal ropivacaine versus ropivacaine with fentanyl in transurethral resection operations. Saudi J Anaesth. 2014; 8(1):88-91.
[23] Bremerich DH, Fetsch N, Zwissler BC, Meininger D, Gogarten W, Byhahn C. Comparison of intrathecal bupivacaine and levobupivacaine combined with opioids for Caesarean section. Curr Med Res Opin. 2007; 23(12):3047-54.
[24] Chen G, Gong M, Liu Y. Comparison of ropivacaine plus sufentanil and ropivacaine plus dexmedetomidine for labor epidural analgesia: A randomized controlled trial protocol. Medicine (Baltimore). 2020; 99(36):e22113.
[25] Kirksey MA, Haskins SC, Cheng J, Liu SS. Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review. PLoS One. 2015; 10(9):e0137312.
[26] Chavan SG, Koshire AR, Panbude P. Effect of addition of fentanyl to local anesthetic in brachial plexus block on duration of analgesia. Anesth Essays Res. 2011; 5(1):39-42.
[27] Bundscherer A, Malsy M, Gebhardt K, Metterlein T, Plank C, Wiese CH, et al. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015; 95-96:126-31.
[28] Seetharam, K. R., & Bhat, G. (2015). Effects of isobaric ropivacaine with or without fentanyl in subarachnoid blockade: A prospective double-blind, randomized study. Anesth Essays Res. 9(2):173-7.
[29] Macias, A., Monedero, P., Adame, M., Torre, W., Fidalgo, I., & Hidalgo, F. A randomized, double-blinded comparison of thoracic epidural ropivacaine, ropivacaine/fentanyl, or bupivacaine/fentanyl for postthoracotomy analgesia. Anesth Analg. 2002; 95(5):1344-50.
[30] Nishikawa K, Kanaya N, Nakayama M, Igarashi M, Tsunoda K, Namiki A. Fentanyl improves analgesia but prolongs the onset of axillary brachial plexus block by peripheral mechanism. Anesth Analg. 2000; 91(2):384-7.
| Files | ||
| Issue | Article in Press |
|
| Section | Research Article(s) | |
| Keywords | ||
| Splanchnic block pain pancreatic cancer pharmaceutical painkillers | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
